KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Yuxiang Ma, Wenfeng Fang, Yang Zhang, Yunpeng Yang, Shaodong Hong, Yuanyuan Zhao, Shuang Xie, Jun Ge, Hao Jin Zhou, Hongyun Zhao, Li Zhang*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science